Marbocyl P 80 mg Tablet

Երկիր: Միացյալ Թագավորություն

Լեզու: անգլերեն

Աղբյուրը: VMD (Veterinary Medicines Directorate)

Ակտիվ բաղադրիչ:

Marbofloxacin

Հասանելի է:

Vetoquinol UK Ltd

ATC կոդը:

QJ01MA93

INN (Միջազգային անվանումը):

Marbofloxacin

Դեղագործական ձեւ:

Tablet

Ռեկվիզորի տեսակը:

POM-V - Prescription Only Medicine – Veterinarian

Թերապեւտիկ խումբ:

Dogs

Թերապեւտիկ տարածք:

Antimicrobial

Լիազորման կարգավիճակը:

Authorized

Հաստատման ամսաթիվը:

2003-06-20

Ապրանքի հատկությունները

Revised: September 2023
AN: 00690/2023
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
MARBOCYL P 80 mg tablet
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Ingredient Marbofloxacin 80mg per tablet
FOR A FULL LIST OF EXCIPIENTS, SEE SECTION 6.1
3.
PHARMACEUTICAL FORM
Beige brown spotted round tablet
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
DOGS
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Marbofloxacin is indicated in the treatment of:

skin and soft tissue infections (skinfold pyoderma, impetigo,
folliculitis,
furunculosis, cellulitis) caused by susceptible strains of organisms.

urinary tract infections (UTI) associated or not with prostatitis
caused by
susceptible strains of organisms.

respiratory tract infections caused by susceptible strains of
organisms.
4.3
CONTRA-INDICATIONS
Marbofloxacin should not be used in dogs aged less than 12 months, or
less than 18 months for exceptionally large breeds of dogs, such as
Great
Danes, Briard, Bernese Bonvier and Mastiffs, with a longer growth
period.
Do not use in cases of hypersensitivity to fluoroquinolones or any of
the
excipients of the product.
Do not use in cases of resistance against quinolones since (almost)
complete cross-resistance exists against other fluoroquinolones.
Revised: September 2023
AN: 00690/2023
Page 2 of 5
Not suitable for infections resulting from strict anaerobes, yeast or
fungi.
Do not use in cats. For the treatment of this species, a 5 mg tablet
is
available.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Nil
4.5
SPECIAL PRECAUTIONS FOR USE
(I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The fluoroquinolones have been shown to induce erosion of articular
cartilage in juvenile dogs and care should be taken to dose accurately
especially in young animals.
The fluoroquinolones are also known for their potential neurological
side
effects. Cautious use is recommended in dogs and cats diagnosed as
suffering from epilepsy.
A low urinary pH could have an inhibitory effect on the activit